Schedule 13G ownership disclosure
ADVAXIS INC
Security class unavailable · CUSIP: 007624208
Event date: 2018-09-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,166,666
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-056836
- Form type
- SC 13G
- Filer
- Ayala Pharmaceuticals, Inc.
- CIK
- CIK 1100397
- Filed
- Sep 14, 2018
- Reporting period
- Sep 07, 2018
- Description
- Schedule 13G beneficial ownership